Neoprobe Corporation to Present at Acumen BioFin Conference

DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that its President and Chief Executive Officer, David Bupp, will present on Tuesday, May 15, 2007 at 10:05AM local time and 4:05AM ET, in the Zephyr Salon, during the Acumen BioFin (Rodman & Renshaw) 4th Annual Global Healthcare Conference to be held at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Mr. Bupp’s presentation will provide an overview of the company’s technology and business strategy.
MORE ON THIS TOPIC